BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32439469)

  • 1. The role of thymus and activation-regulated chemokine as a marker of severity of atopic dermatitis.
    Himadri ; George R; Mathew L; Shanmugam V; Mani T; Jeyaseelan L
    J Am Acad Dermatol; 2021 Feb; 84(2):545-547. PubMed ID: 32439469
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
    Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
    Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum squamous cell carcinoma antigen (SCCA)-2 correlates with clinical severity of pediatric atopic dermatitis in Ishigaki cohort.
    Takeuchi S; Furusyo N; Ono J; Azuma Y; Takemura M; Esaki H; Yamamura K; Mitamura Y; Tsuji G; Kiyomatsu-Oda M; Hayashi J; Izuhara K; Furue M
    J Dermatol Sci; 2019 Aug; 95(2):70-75. PubMed ID: 31378660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TARC (thymus and activation regulated chemokine)].
    Nakamura K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():41-5. PubMed ID: 20941997
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.
    Hulshof L; Overbeek SA; Wyllie AL; Chu MLJN; Bogaert D; de Jager W; Knippels LMJ; Sanders EAM; van Aalderen WMC; Garssen J; Van't Land B; Sprikkelman AB;
    Front Immunol; 2018; 9():630. PubMed ID: 29966024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting.
    Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Am Acad Dermatol; 2020 May; 82(5):1247-1249. PubMed ID: 31884090
    [No Abstract]   [Full Text] [Related]  

  • 7. Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable.
    Ozawa M; Sasahara Y; Aiba S
    J Dermatol; 2018 May; 45(5):606-608. PubMed ID: 29399856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of platelets in the production of thymus and activation-regulated chemokine in children: A case series study.
    Okura Y; Takahashi Y; Kobayashi I
    Allergol Int; 2019 Apr; 68(2):277-278. PubMed ID: 30470479
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
    Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
    Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG
    J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
    Gu CY; Gu L; Dou X
    Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy.
    Miyahara H; Okazaki N; Nagakura T; Korematsu S; Izumi T
    Clin Exp Allergy; 2011 Feb; 41(2):186-91. PubMed ID: 21054588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS).
    Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J
    Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
    Thijs JL; Drylewicz J; Fiechter R; Strickland I; Sleeman MA; Herath A; May RD; Bruijnzeel-Koomen CAFM; Knol EF; Giovannone B; de Bruin-Weller MS; Nierkens S; Hijnen DJ
    J Allergy Clin Immunol; 2017 Dec; 140(6):1703-1705. PubMed ID: 28823810
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status.
    Ahrens B; Schulz G; Bellach J; Niggemann B; Beyer K
    Pediatr Allergy Immunol; 2015 Nov; 26(7):634-40. PubMed ID: 26102348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria.
    Machura E; Rusek-Zychma M; Jachimowicz M; Wrzask M; Mazur B; Kasperska-Zajac A
    Pediatr Allergy Immunol; 2012 May; 23(3):278-84. PubMed ID: 22017510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.
    Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H
    J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis.
    Kimura T; Sugaya M; Suga H; Morimura S; Miyamoto A; Kai H; Kagami S; Yanaba K; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Acta Derm Venereol; 2014 May; 94(3):331-2. PubMed ID: 24104601
    [No Abstract]   [Full Text] [Related]  

  • 20. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
    Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.